Xiangyu Medical Co.,Ltd (SHA:688626)
China · Delayed Price · Currency is CNY 46.74
+1.01 (2.21%)
Jul 21, 2025, 11:29 AM CST
Xiangyu Medical Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 86.82 | 102.94 | 227.14 | 125.47 | 201.9 | 196.26 | Upgrade |
Depreciation & Amortization | 37.95 | 37.95 | 18.08 | 16.06 | 11.37 | 10.78 | Upgrade |
Other Amortization | 3.99 | 3.99 | 1.51 | 1.63 | 0.48 | 0.28 | Upgrade |
Loss (Gain) From Sale of Assets | -0.07 | -0.07 | -0.01 | - | -0.02 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 0.05 | 0.05 | 0.02 | 0.25 | 0.04 | 0.14 | Upgrade |
Loss (Gain) From Sale of Investments | -1.4 | -1.4 | -6.06 | -12.59 | -12.13 | 0.31 | Upgrade |
Provision & Write-off of Bad Debts | 3.19 | 3.19 | 2.15 | 0.07 | 2.2 | 1.7 | Upgrade |
Other Operating Activities | 33.34 | 13.66 | 13.49 | 3.03 | 0.49 | 1.84 | Upgrade |
Change in Accounts Receivable | -20.71 | -20.71 | -44.14 | 18.03 | -31.44 | -11.77 | Upgrade |
Change in Inventory | -6 | -6 | -27.68 | -65.8 | -29.31 | 12.67 | Upgrade |
Change in Accounts Payable | 38.23 | 38.23 | 48.4 | 94.37 | 23.84 | 4.54 | Upgrade |
Change in Other Net Operating Assets | 5.1 | 5.1 | 2.83 | - | - | - | Upgrade |
Operating Cash Flow | 182.14 | 178.59 | 227.91 | 186.7 | 165.88 | 216.4 | Upgrade |
Operating Cash Flow Growth | -12.75% | -21.64% | 22.07% | 12.55% | -23.35% | 38.77% | Upgrade |
Capital Expenditures | -398.25 | -438.89 | -479.26 | -203.07 | -133.91 | -139.71 | Upgrade |
Sale of Property, Plant & Equipment | 0.08 | 0.08 | 0.09 | 0.07 | 0.04 | 0.03 | Upgrade |
Divestitures | - | - | 0.23 | - | - | - | Upgrade |
Investment in Securities | 161.8 | 161.8 | 232.42 | 5.42 | -657.2 | - | Upgrade |
Other Investing Activities | -94.41 | 1.26 | 11.98 | 18.68 | 9.03 | 0.27 | Upgrade |
Investing Cash Flow | -330.77 | -275.76 | -234.54 | -178.9 | -782.04 | -139.41 | Upgrade |
Short-Term Debt Issued | - | 516 | 82 | 60.15 | - | 52.29 | Upgrade |
Total Debt Issued | 540.09 | 516 | 82 | 60.15 | - | 52.29 | Upgrade |
Short-Term Debt Repaid | - | -202.68 | -73.3 | -47.78 | -50.09 | - | Upgrade |
Long-Term Debt Repaid | - | -1.51 | -1.09 | - | - | - | Upgrade |
Total Debt Repaid | -311.17 | -204.18 | -74.38 | -47.78 | -50.09 | - | Upgrade |
Net Debt Issued (Repaid) | 228.92 | 311.82 | 7.62 | 12.37 | -50.09 | 52.29 | Upgrade |
Issuance of Common Stock | - | - | - | - | 1,086 | - | Upgrade |
Repurchase of Common Stock | -77.57 | -77.57 | -25.66 | -73.27 | - | - | Upgrade |
Common Dividends Paid | -92.85 | -85.59 | -40.46 | -59.94 | -59.41 | -0.81 | Upgrade |
Other Financing Activities | 77.52 | -0.28 | - | 3.8 | -21.08 | -3.3 | Upgrade |
Financing Cash Flow | 136.01 | 148.38 | -58.5 | -117.04 | 955.13 | 48.19 | Upgrade |
Foreign Exchange Rate Adjustments | -0.05 | -0.07 | -0.02 | -0.02 | -0.02 | 0.06 | Upgrade |
Net Cash Flow | -12.67 | 51.15 | -65.15 | -109.27 | 338.95 | 125.24 | Upgrade |
Free Cash Flow | -216.11 | -260.3 | -251.35 | -16.37 | 31.97 | 76.69 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -58.31% | -43.14% | Upgrade |
Free Cash Flow Margin | -28.42% | -35.01% | -33.75% | -3.35% | 6.11% | 15.48% | Upgrade |
Free Cash Flow Per Share | -1.39 | -1.67 | -1.59 | -0.10 | 0.21 | 0.64 | Upgrade |
Cash Interest Paid | - | - | - | 0.19 | - | - | Upgrade |
Cash Income Tax Paid | 38.88 | 44.21 | 58.42 | 43.73 | 62.21 | 65.34 | Upgrade |
Levered Free Cash Flow | -309.85 | -346.73 | -391.43 | -65.55 | -56.43 | -21.89 | Upgrade |
Unlevered Free Cash Flow | -305.07 | -344.46 | -389.77 | -65.43 | -56.43 | -21.78 | Upgrade |
Change in Net Working Capital | -8.37 | -4.21 | 52.3 | -86.41 | 23.21 | -5.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.